JP2007505102A5 - - Google Patents

Download PDF

Info

Publication number
JP2007505102A5
JP2007505102A5 JP2006526008A JP2006526008A JP2007505102A5 JP 2007505102 A5 JP2007505102 A5 JP 2007505102A5 JP 2006526008 A JP2006526008 A JP 2006526008A JP 2006526008 A JP2006526008 A JP 2006526008A JP 2007505102 A5 JP2007505102 A5 JP 2007505102A5
Authority
JP
Japan
Prior art keywords
oxo
ylmethyl
oxazolidine
fluorophenyl
acetamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006526008A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007505102A (ja
JP4917432B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IN2004/000276 external-priority patent/WO2005054234A2/en
Publication of JP2007505102A publication Critical patent/JP2007505102A/ja
Publication of JP2007505102A5 publication Critical patent/JP2007505102A5/ja
Application granted granted Critical
Publication of JP4917432B2 publication Critical patent/JP4917432B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006526008A 2003-09-08 2004-09-08 インビボ効力が改良された抗菌活性を有する置換ピペリジノフェニルオキサゾリジノン化合物 Expired - Fee Related JP4917432B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN924MU2003 2003-09-08
IN924/MUM/2003 2003-09-08
PCT/IN2004/000276 WO2005054234A2 (en) 2003-09-08 2004-09-08 Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy

Publications (3)

Publication Number Publication Date
JP2007505102A JP2007505102A (ja) 2007-03-08
JP2007505102A5 true JP2007505102A5 (enExample) 2007-11-01
JP4917432B2 JP4917432B2 (ja) 2012-04-18

Family

ID=34640331

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006526008A Expired - Fee Related JP4917432B2 (ja) 2003-09-08 2004-09-08 インビボ効力が改良された抗菌活性を有する置換ピペリジノフェニルオキサゾリジノン化合物

Country Status (8)

Country Link
US (2) US7687627B2 (enExample)
EP (1) EP1664038A2 (enExample)
JP (1) JP4917432B2 (enExample)
AU (1) AU2004295208A1 (enExample)
BR (1) BRPI0413413A (enExample)
CA (1) CA2537559C (enExample)
EA (1) EA200600374A1 (enExample)
WO (1) WO2005054234A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687627B2 (en) * 2003-09-08 2010-03-30 Wockhardt Limited Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
WO2007004049A1 (en) * 2005-07-06 2007-01-11 Pharmacia & Upjohn Company Llc Oxazolidinones containing azetidine as antibacterial agents
JP5313126B2 (ja) * 2006-05-09 2013-10-09 ウォックハート リミテッド 置換ピペリジノフェニルオキサゾリジノン
CN101616588B (zh) * 2006-09-25 2013-09-25 沃克哈特研究中心 取代的哌啶子基苯基噁唑烷酮
WO2009037542A2 (en) * 2007-09-20 2009-03-26 Glenmark Pharmaceuticals, S.A. Spirocyclic compounds as stearoyl coa desaturase inhibitors
EP2072513A1 (en) * 2007-12-17 2009-06-24 Ferrer Internacional, S.A. A cyano piperidinyl-phenil-oxazolidinone and use thereof
EP2254892B1 (en) 2008-03-26 2014-04-23 Global Alliance For Tb Drug Development Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones
EP2141161A1 (en) * 2008-07-01 2010-01-06 Ferrer Internacional, S.A. 3-cyanopyrrolidinyl-phenyl-oxazolidinones as antibacterial agents
EP2410854B1 (en) * 2009-03-27 2016-06-29 Council of Scientific & Industrial Research Substituted 1, 4-dioxa-8-azaspiro ý4,5¨decanes useful as fungicides and a process for the preparation thereof
CA2816515A1 (en) * 2010-11-03 2012-05-10 Wockhardt Limited Process for the preparation of phosphoric acid mono-(1-{4-[(s)-5-(acetylaminomethyl)-2-oxo-oxazolidin-3-yl]-2,6-difluorophenyl}-4-methoxymethylpiperidin-4-yl) ester
US9359344B2 (en) 2011-09-29 2016-06-07 Xuanzhu Pharma Co., Ltd. Biaryl heterocycle substituted oxazolidinone antibacterial agents
WO2015066413A1 (en) * 2013-11-01 2015-05-07 Novartis Ag Oxazolidinone hydroxamic acid compounds for the treatment of bacterial infections
WO2016079757A2 (en) * 2014-11-19 2016-05-26 Symed Labs Limited Novel processes for preparing 5-hydroxymethyl-oxazolidin-2-one derivatives
WO2019081210A1 (en) * 2017-10-27 2019-05-02 Huntsman International Llc CATALYSTS FOR MANUFACTURING OXAZOLIDINONE MATERIALS
CN112543756A (zh) * 2018-07-25 2021-03-23 卡迪拉保健有限公司 用于治疗哺乳动物感染的经取代噁唑烷酮类
WO2020234636A1 (en) 2019-05-17 2020-11-26 Cadila Healthcare Limited Novel compounds for the treatment of mammalian infections

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3344145A (en) * 1963-10-21 1967-09-26 Geschickter Fund Med Res N-substituted phenoxyalkyl or phenylthioalkyl-mono azaspiroalkanes
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5489689A (en) * 1993-09-30 1996-02-06 Mallinckrodt Chemical, Inc. Preparation of piperidine derivatives
US5668286A (en) * 1994-03-15 1997-09-16 Pharmacia & Upjohn Company Oxazolidinone derivatives and pharmaceutical compositions containing them
JPH0873455A (ja) * 1994-03-15 1996-03-19 Upjohn Co:The オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
SI0788498T1 (en) * 1994-10-26 2001-12-31 Upjohn Co Phenyloxazolidinone antimicrobials
ES2214546T3 (es) * 1995-09-15 2004-09-16 PHARMACIA & UPJOHN COMPANY N-oxidos de aminoariloxazolidinona.
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
GB9609919D0 (en) * 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
RU2208613C2 (ru) * 1997-05-30 2003-07-20 Фармация Энд Апджон Компани Оксазолидиноновые антибактериальные агенты, содержащие тиокарбонильную функциональную группу
CA2333332A1 (en) * 1998-06-05 1999-12-16 Astrazeneca Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
GB9821938D0 (en) * 1998-10-09 1998-12-02 Zeneca Ltd Chemical compounds
JP2000204084A (ja) * 1998-11-11 2000-07-25 Hokuriku Seiyaku Co Ltd チオカルバミド酸誘導体
JP3270834B2 (ja) * 1999-01-27 2002-04-02 ファイザー・プロダクツ・インク 抗がん剤として有用なヘテロ芳香族二環式誘導体
CA2374383A1 (en) * 1999-07-28 2001-02-08 Pharmacia & Upjohn Company Oxazolidinones and their use as antiinfectives
US6608081B2 (en) * 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
GB2356389B (en) * 1999-09-02 2003-07-16 Bruce Stanley Gunton Loading bay dock control
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
WO2002046156A2 (en) * 2000-12-06 2002-06-13 Sepracor, Inc. 4,4-disubstituted piperidines for use as dopamine, serotonin and norepinephrine ligands
JP2005503435A (ja) * 2001-04-17 2005-02-03 メルク アンド カンパニー インコーポレーテッド ビシクロ[3.1.0]ヘキサン含有オキサゾリジノン抗生物質及びその誘導体
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
CA2492194A1 (en) * 2002-07-11 2004-01-22 Wockhardt Limited Antibacterial cyano-(substituted)-methylenepiperidinophenyl oxazolidinones targeting multiple ribonucleoproteins sites
US7405228B2 (en) * 2002-07-11 2008-07-29 Wockhardt Limited Antibacterial cyano-(substituted)-methylenepiperidinophenyl oxazolidinones targeting multiple ribonucleoprotein sites
AU2003274676A1 (en) * 2002-07-11 2004-02-02 Yati Chugh Antimicrobial oxazolidinones, process of their preparation, and pharmaceutical compositions containing them
KR100490643B1 (ko) * 2002-10-29 2005-05-19 한국과학기술연구원 새로운 메틸리덴 피페리딘일 옥사졸리딘온 유도체 및이들의 제조방법
US7687627B2 (en) * 2003-09-08 2010-03-30 Wockhardt Limited Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
JP5313126B2 (ja) * 2006-05-09 2013-10-09 ウォックハート リミテッド 置換ピペリジノフェニルオキサゾリジノン

Similar Documents

Publication Publication Date Title
JP2007505102A5 (enExample)
KR101799007B1 (ko) 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 설폰아마이드 유도체 화합물 및 이를 포함하는 약제학적 조성물
CN110831945B (zh) 用于治疗疼痛的11,13-修饰的石房蛤毒素类化合物
KR102564925B1 (ko) 안드로겐 수용체의 표적화된 분해를 위한 화합물 및 방법
ES2379744T3 (es) Antagonistas de piridil-piperidina de los receptores de orexinas
ES2397188T3 (es) Compuestos de diazepano sustituidos como antagonistas del receptor de orexina
DK2928867T3 (en) PYRIDIN-2 AMIDES USED AS CB2 AGONISTS
US6812226B2 (en) P2X7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular disease
JP2020528918A (ja) アンドロゲン受容体の標的化分解のための化合物および方法
JP6500010B2 (ja) 新規ピリジン誘導体
CN109563057B (zh) 磺酰胺化合物或其盐
CA2537559A1 (en) Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy
MX2008001077A (es) Carboxamidas fungicidas.
AU2015214961A1 (en) Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
KR20130036171A (ko) 트리시클릭 헤테로시클릭 화합물
TW201211053A (en) Spiro compound and drug for activating adiponectin receptor
RU2013120338A (ru) Производное 1,2,4-триазолана
EP2077719B1 (en) Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
CA2856824A1 (en) Cyclic urea derivatives as androgen receptor antagonists
WO2018193297A1 (en) Novel compounds as ror-gamma modulators
CN1378546A (zh) 抗菌的磺内酰胺和磺内酯衍生的噁唑烷酮
OA17919A (en) Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B.
HK40000205B (en) Sulfonamide compound or salt thereof
BR112018001720B1 (pt) Compostos de derivado de 1,3,4-oxadiazol sulfonamida como inibidor de histona desacetilase 6 e a composição farmacêutica que compreende os mesmos